Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease-Reference-Cited by-同舟云学术

Evidence-Based Recommendations for Medical Management of Peripheral Artery Disease

Published:2021-06-01 Issue:6 Volume:28 Page:573-583
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Golledge Jonathan¹²³,Drovandi Aaron¹²

Affiliation:

1. Queensland Research Centre for Peripheral Vascular Disease, College of Medicine and Dentistry, James Cook University

2. The Australian Institute of Tropical Health and Medicine, James Cook University

3. The Department of Vascular and Endovascular Surgery, The Townsville University Hospital

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/6/28_62778/_pdf

Reference77 articles.

1. 1) Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, Norman PE, Sampson UKA, Williams LJ, Mensah GA, Criqui MH. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet, 2013; 382: 1329-1340

2. 2) Conte MS, Bradbury AW, Kolh P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad MH; GVG Writing Group. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg, 2019; 58: S1-S109

3. 3) McDermott MM, Ferrucci L, Liu K, Guralnik JM, Tian L, Liao Y, Criqui MH. Leg symptom categories and rates of mobility decline in peripheral arterial disease. J Am Geriatr Soc, 2010; 58: 1256-1262

4. 4) Issa SM, Hoeks SE, Scholte op Reimer WJ, Van Gestel YR, Lenzen MJ, Verhagen HJ, Pedersen SS, Poldermans D. Health-related quality of life predicts long-term survival in patients with peripheral artery disease. Vasc Med, 2010; 15: 163-169

5. 5) Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS. Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk). Circulation, 2018; 137: 338

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics;European Heart Journal;2024-08-27

2. Appropriate Use Criteria Committees: The professional society role in the development and implementation of Appropriate Use Criteria;Seminars in Vascular Surgery;2024-06

3. Avaliação sistemática dos preditores de acidente vascular cerebral em pacientes com doença arterial periférica;STUDIES IN HEALTH SCIENCES;2024-05-28

4. Management and Pharmacological Treatment of Peripheral Arterial Disease;Journal of Pharmacy Practice;2024-05-01

5. Management of claudicants with low toe-brachial index in a Veteran population;Vascular;2024-04-08